Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+101.5%
5Y CAGR+59.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+101.5%/yr
vs -22.8%/yr prior
5Y CAGR
+59.2%/yr
Recent acceleration
Acceleration
+124.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $288.90M | +649.5% |
| 2024 | $38.55M | -11.2% |
| 2023 | $43.41M | +22.9% |
| 2022 | $35.33M | +56.5% |
| 2021 | $22.58M | -20.0% |
| 2020 | $28.24M | +77.2% |
| 2019 | $15.93M | -84.0% |
| 2018 | $99.53M | +161.2% |
| 2017 | $38.10M | +1.1% |
| 2016 | $37.68M | - |